List of Chapters/Sections(Table Of Content)
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Cell-free Tumor DNA Detection
1.2 Key Market Segments
1.2.1 Cell-free Tumor DNA Detection Segment by Type
1.2.2 Cell-free Tumor DNA Detection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Cell-free Tumor DNA Detection Market Overview
2.1 Global Market Overview
2.1.1 Global Cell-free Tumor DNA Detection Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Cell-free Tumor DNA Detection Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Cell-free Tumor DNA Detection Market Competitive Landscape
3.1 Global Cell-free Tumor DNA Detection Sales by Manufacturers (2019-2024)
3.2 Global Cell-free Tumor DNA Detection Revenue Market Share by Manufacturers (2019-2024)
3.3 Cell-free Tumor DNA Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cell-free Tumor DNA Detection Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cell-free Tumor DNA Detection Sales Sites, Area Served, Product Type
3.6 Cell-free Tumor DNA Detection Market Competitive Situation and Trends
3.6.1 Cell-free Tumor DNA Detection Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cell-free Tumor DNA Detection Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Cell-free Tumor DNA Detection Industry Chain Analysis
4.1 Cell-free Tumor DNA Detection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Cell-free Tumor DNA Detection Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Cell-free Tumor DNA Detection Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell-free Tumor DNA Detection Sales Market Share by Type (2019-2024)
6.3 Global Cell-free Tumor DNA Detection Market Size Market Share by Type (2019-2024)
6.4 Global Cell-free Tumor DNA Detection Price by Type (2019-2024)
7 Cell-free Tumor DNA Detection Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell-free Tumor DNA Detection Market Sales by Application (2019-2024)
7.3 Global Cell-free Tumor DNA Detection Market Size (M USD) by Application (2019-2024)
7.4 Global Cell-free Tumor DNA Detection Sales Growth Rate by Application (2019-2024)
8 Cell-free Tumor DNA Detection Market Segmentation by Region
8.1 Global Cell-free Tumor DNA Detection Sales by Region
8.1.1 Global Cell-free Tumor DNA Detection Sales by Region
8.1.2 Global Cell-free Tumor DNA Detection Sales Market Share by Region
8.2 North America
8.2.1 North America Cell-free Tumor DNA Detection Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cell-free Tumor DNA Detection Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cell-free Tumor DNA Detection Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cell-free Tumor DNA Detection Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cell-free Tumor DNA Detection Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Biocept Inc.
9.1.1 Biocept Inc. Cell-free Tumor DNA Detection Basic Information
9.1.2 Biocept Inc. Cell-free Tumor DNA Detection Product Overview
9.1.3 Biocept Inc. Cell-free Tumor DNA Detection Product Market Performance
9.1.4 Biocept Inc. Business Overview
9.1.5 Biocept Inc. Cell-free Tumor DNA Detection SWOT Analysis
9.1.6 Biocept Inc. Recent Developments
9.2 Bio-Rad Laboratories Inc.
9.2.1 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Basic Information
9.2.2 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Product Overview
9.2.3 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Product Market Performance
9.2.4 Bio-Rad Laboratories Inc. Business Overview
9.2.5 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection SWOT Analysis
9.2.6 Bio-Rad Laboratories Inc. Recent Developments
9.3 Fluxion Biosciences Inc.
9.3.1 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Basic Information
9.3.2 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Product Overview
9.3.3 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Product Market Performance
9.3.4 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection SWOT Analysis
9.3.5 Fluxion Biosciences Inc. Business Overview
9.3.6 Fluxion Biosciences Inc. Recent Developments
9.4 F. Hoffmann-La Roche AG
9.4.1 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Basic Information
9.4.2 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Product Overview
9.4.3 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Product Market Performance
9.4.4 F. Hoffmann-La Roche AG Business Overview
9.4.5 F. Hoffmann-La Roche AG Recent Developments
9.5 Sysmex Europe SE
9.5.1 Sysmex Europe SE Cell-free Tumor DNA Detection Basic Information
9.5.2 Sysmex Europe SE Cell-free Tumor DNA Detection Product Overview
9.5.3 Sysmex Europe SE Cell-free Tumor DNA Detection Product Market Performance
9.5.4 Sysmex Europe SE Business Overview
9.5.5 Sysmex Europe SE Recent Developments
9.6 Qiagen
9.6.1 Qiagen Cell-free Tumor DNA Detection Basic Information
9.6.2 Qiagen Cell-free Tumor DNA Detection Product Overview
9.6.3 Qiagen Cell-free Tumor DNA Detection Product Market Performance
9.6.4 Qiagen Business Overview
9.6.5 Qiagen Recent Developments
9.7 NeoGenomics Laboratories Inc.
9.7.1 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Basic Information
9.7.2 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Product Overview
9.7.3 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Product Market Performance
9.7.4 NeoGenomics Laboratories Inc. Business Overview
9.7.5 NeoGenomics Laboratories Inc. Recent Developments
9.8 Menarini Silicon Biosystems
9.8.1 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Basic Information
9.8.2 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Product Overview
9.8.3 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Product Market Performance
9.8.4 Menarini Silicon Biosystems Business Overview
9.8.5 Menarini Silicon Biosystems Recent Developments
9.9 Illumina Inc.
9.9.1 Illumina Inc. Cell-free Tumor DNA Detection Basic Information
9.9.2 Illumina Inc. Cell-free Tumor DNA Detection Product Overview
9.9.3 Illumina Inc. Cell-free Tumor DNA Detection Product Market Performance
9.9.4 Illumina Inc. Business Overview
9.9.5 Illumina Inc. Recent Developments
9.10 Guardant Health Inc.
9.10.1 Guardant Health Inc. Cell-free Tumor DNA Detection Basic Information
9.10.2 Guardant Health Inc. Cell-free Tumor DNA Detection Product Overview
9.10.3 Guardant Health Inc. Cell-free Tumor DNA Detection Product Market Performance
9.10.4 Guardant Health Inc. Business Overview
9.10.5 Guardant Health Inc. Recent Developments
9.11 Shanghai Biotecan Medical Diagnostics Co.,Ltd.
9.11.1 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Basic Information
9.11.2 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Product Overview
9.11.3 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Product Market Performance
9.11.4 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Business Overview
9.11.5 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Recent Developments
10 Cell-free Tumor DNA Detection Market Forecast by Region
10.1 Global Cell-free Tumor DNA Detection Market Size Forecast
10.2 Global Cell-free Tumor DNA Detection Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cell-free Tumor DNA Detection Market Size Forecast by Country
10.2.3 Asia Pacific Cell-free Tumor DNA Detection Market Size Forecast by Region
10.2.4 South America Cell-free Tumor DNA Detection Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cell-free Tumor DNA Detection by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Cell-free Tumor DNA Detection Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Cell-free Tumor DNA Detection by Type (2025-2030)
11.1.2 Global Cell-free Tumor DNA Detection Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Cell-free Tumor DNA Detection by Type (2025-2030)
11.2 Global Cell-free Tumor DNA Detection Market Forecast by Application (2025-2030)
11.2.1 Global Cell-free Tumor DNA Detection Sales (K Units) Forecast by Application
11.2.2 Global Cell-free Tumor DNA Detection Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
